Central AsianResearch Index

PREVALENCE OF MULTIPLE SCLEROSIS IN THE NORTHERN REGIONS OF THE REPUBLIC OF AZERBAIJAN: ӘЗІРБАЙЖАН РЕСПУБЛИКАСЫНЫҢ СОЛТҮСТІК ӨҢІРЛЕРІНДЕ ШАШЫРАҢҚЫ СКЛЕРОЗДЫҢ ТАРАЛУЫ

РАСПРОСТРАНЁННОСТЬ РАССЕЯННОГО СКЛЕРОЗА В СЕВЕРНЫХ РЕГИОНАХ АЗЕРБАЙДЖАНСКОЙ РЕСПУБЛИКИ

Introduction. Multiple sclerosis (MS) is a chronic immune-mediated inflammatory disease of the central nervous system characterized by demyelination and neuroinflammation. Aim. This study investigates the prevalence and demographics of MS in the northern regions of Azerbaijan, providing insights for targeted healthcare strategies. Materials and Methods. This was a prospective, single-center, registry-based observational study involving patients referred from regional clinics or those presenting directly. The study was conducted at the Neurology Center of the Ministry of Health of Azerbaijan, from 01.01.2013, to 31.12.2022. Newly diagnosed or follow-up MS cases were included, with referrals from neurologists across the republic or self-referral to the center. Diagnostic protocols followed the Ministry of Health's "Clinical Protocol for the Diagnosis and Treatment of MS". Prevalence rates per 100,000 population were calculated and standardized using international and local demographic benchmarks. Statistical analysis included Pearson’s chi-square, Student’s t-tests, and Mann-Whitney U-tests, with significance set at p<0.05. Results. In 2022, MS prevalence in the northern region of Azerbaijan was 18.25±1.25/100,000 (95% CI: 15.80–20.70), higher in urban (28.27±2.80/100,000, 95% CI: 22.78–33.75) than in rural areas (13.76±1.31/100,000, 95% CI: 11.20–16.32) (p<0.0001). The mean diagnosis age was 35.39±8.65 years (95% CI: 34.23–36.54), disease onset at 29.89±8.57 years (95% CI: 28.74–31.03), and the diagnostic delay was 5.50±4.24 years (95% CI: 4.93–6.07). Among living registered patients included in the point–prevalence analysis, women accounted for 63.4% of cases (135/213). The prevalence was significantly higher among women than men (23.10±1.99 vs. 13.38±1.51 per 100,000; p<0.001). Conclusion. MS prevalence in northern region Azerbaijan is lower than in most European regions but comparable to neighboring countries. Findings highlight the need for better diagnostics in rural areas and establish a baseline for studying environmental and other risk factors. Key words: Azerbaijan, delayed diagnosis, epidemiology, multiple sclerosis, prevalence.

Сведения

Журнал
Vestnik
Опубликовано
2026 · № 2(77), С. 1-12
Язык
Казахский
ISSN
2524-0684 · 2524-0692
Издатель
Asfendiyarov Kazakh National Medical University
Аффилиации
Azerbaijan Medical University